Introduction {#Sec1}
============

Visual hallucinations are one of the most common and distressing non-motor problems in Parkinson's disease (PD) (Rabey [@CR64]; Bernal-Pacheco et al. [@CR9]), and predict dementia and mortality (Fenelon et al. [@CR26]; Aarsland et al. [@CR1]). However their underlying biology remains poorly understood. Hippocampal pathology is associated with visual hallucinations in other psychiatric disorders (Isaacson [@CR42]; Oertel et al. [@CR58]; Vignal et al. [@CR77]). The hippocampus is in a unique position for the conjunction of spatial and non-spatial contextual information (Goodale and Milner [@CR33]) and plays an important role in encoding and retrieval of event memories (Behrendt [@CR8]). In experimental animal models, blocking neuronal activity in one hippocampus in rats modulates activity in the contralateral hippocampus and leads to cognitive disorganization (Olypher et al. [@CR60]). This has led to the suggestion that inappropriate integration of visual information by the hippocampi in psychosis could induce hallucinations instead of reflecting reality (Olypher et al. [@CR60]).

There is a preliminary evidence linking macroscopic changes in the hippocampus to visual hallucinations in Parkinson's disease. For example, greater numbers of Lewy bodies in medial temporal lobe are found in PD patients with visual hallucinations (Kalaitzakis et al. [@CR45]; Gallagher et al. [@CR30]); and hippocampal atrophy has been reported to be correlated with visual hallucinations (Ibarretxe-Bilbao et al. [@CR40], [@CR41]). However, no-one has directly examined the pathophysiology of the hippocampus in PD patients with visual hallucinations. The present study adopted a multimodal MRI approach to test the hypothesis that structural and functional alterations of the hippocampal formation contribute to visual hallucinations in PD. We compared hippocampal volume, shape, gray matter microstructure, and functional connectivity in individuals with PD with and without visual hallucinations, and healthy controls (HC). We also compared visuospatial memory function in each group because this ability depends upon the hippocampus (Dupret et al. [@CR22]) and impaired visuospatial function is, in turn, linked to visual hallucinations (Barnes and Boubert [@CR5]).

Diffusion tensor imaging (DTI) is a non-invasive measure of microstructural integrity of tissue (Taylor and Bushell [@CR75]; Merboldt et al. [@CR52]). Although it has been primarily used to detect regional white matter differences, microstructural anomalies of gray matter can also be examined using DTI. This approach has been successfully applied to investigate the organization of subcortical regions (Cherubini et al. [@CR16]) and hippocampus (Muller et al. [@CR55], [@CR56]; Carlesimo et al. [@CR13]). We predicted that PD individuals with visual hallucinations would have increased hippocampal diffusivity compared to those with uncomplicated PD and healthy individuals.

We also predicted that structural abnormalities of the hippocampus would be accompanied by altered functional connectivity with the rest of brain. Functional connectivity analysis is a relatively novel technique which allows the investigation of large-scale functional networks across the entire brain based on resting-state blood oxygen level dependent (BOLD) signal fluctuations in a very low-frequency range (0.01--0.08 Hz) (Fox and Raichle [@CR28]; Vincent et al. [@CR78]; Zhang and Raichle [@CR84]). Resting-state functional connectivity has identified various intrinsic cortical and cortico-subcortical networks (Fox and Raichle [@CR28]; Robinson et al. [@CR67]; Zhang and Raichle [@CR84]) that are disrupted in Parkinson's Disease (Baudrexel et al. [@CR7]; Hacker et al. [@CR35]) and in patients with schizophrenia who experience auditory and visual hallucinations (Amad et al. [@CR2]). Here we examined hippocampal functional connectivity in patients with PD and visual hallucinations for the first time.

Visuospatial memory impairment has been reported in those with PD and visual hallucinations (Barnes and Boubert [@CR5]), as well individuals with dementia with Lewy bodies (Hamilton et al. [@CR36], [@CR37]). Visuospatial memory relies heavily upon the hippocampus (Dupret et al. [@CR22]) and is thought to contribute to visual hallucinations (Barnes and Boubert [@CR5]). Therefore inter-relationship between hippocampal pathology postulated and this critical cognitive faculty was examined (Robbins et al. [@CR66]). Age and cognitive ability may impact on hippocampus (Atienza et al. [@CR3]; Pereira et al. [@CR63]) and were controlled for. We predicted that hippocampal microstructural integrity and functional connectivity would be associated with impaired visuospatial memory performance in people with PD and visual hallucinations.

Materials and methods {#Sec2}
=====================

Subjects {#Sec3}
--------

Sixty-six individuals (17 HCs and 49 with PD) were initially recruited to the study as approved by the local hospital Research Ethics Committee.

The participants with PD were diagnosed according to the UK Parkinson's Disease Society Brain Bank criteria. Clinical assessments included: Hoehn and Yahr Scale (Hoehn and Yahr [@CR39]) to assess stage of illness; Unified Parkinson's Disease Rating Scale (UPDRS; Fahn and Elton [@CR23]), part III to evaluate PD motor symptom severity; handedness; Montgomery--Åsberg Depression Rating Scale---self-assessment (MADRS-S) (Svanborg and Asberg [@CR73]) to rate depressive symptoms; Mini-mental State Examination (MMSE) (Folstein et al. [@CR27]) to assess cognitive impairment; and the Parkinson Psychosis Rating Scale (PPRS) (Friedberg et al. [@CR29]) which includes a quantitative description of visual hallucinations recorded from patients and caregivers. The score of first item in PPRS was used to measure visual hallucination severity.

The patients with visual hallucinations experienced repetitive and complex visual hallucinations usually of well-formed persons, animals or objects, lasting for at least 4 weeks, and occurring at least once every 4 weeks. Exclusion criteria were: neurological disorders other than Parkinson's disease; major psychiatric disorders; mild to moderate depressive symptoms (MADRS ≥6); cognitive impairment resulting in a MMSE score \<24 (Folstein et al. [@CR27]) to exclude obvious dementia. All subjects were right handed. Thus, 41 individuals were included in this study, and divided into three groups: 12 PD patients with visual hallucinations (PDVH); 15 PD patients without visual hallucinations (PDnonVH); and 14 matched healthy controls (HC).

Patients were described as "on" during the assessment, and their levodopa-equivalent daily dose (LEDD) was calculated according to a standard formula (Krack et al. [@CR46]; Vingerhoets et al. [@CR79]). All subjects were reimbursed for travel expenses, and provided signed informed consent. Demographic and clinical characteristics of the sample are shown in Table [1](#Tab1){ref-type="table"}.Table 1Demographic and clinical profile of HC, PDnonVH, and PDVHDemographicsHC (*n* = 14)PDnonVH (*n* = 15)PDVH (*n* = 12)*p* value*p* value (covaried)Age^a^63 (62,68.75)66 (62,72)70 (64,72.75)0.312n/aGender (male/female)8/610/510/20.35n/aEducation (years)7.6 ± 1.46.3 ± 1.17.2 ± 1.30.75n/aDuration of illness (years)n/a7.1 ± 5.19.1 ± 3.50.27n/aDuration of VH (years)n/an/a2.4 ± 1.1n/an/aHoehn and Yahr stagen/a2.9 ± 0.73.1 ± 0.70.43n/aHead motion (mm)0.093 ± 0.0140.094 ± 0.0210.098 ± 0.0170.98n/aLevodopa dose (mg)n/a689.7 ± 553.9986.9 ± 463.80.17n/aAffected body side (R/B/L)n/a6/3/65/4/30.63n/aMMSE score^a^29 (28,29.25)29 (28,30)28.5 (24,29.75)0.513n/aMADRS-S score^a^0(0,1)0 (0,2.5)1 (0.5,3.25)0.034\*n/aUPDRS-III score^a^n/a17 (14,31)17.5 (11.25,32.5)0.719n/aVisual hallucinations symptom score1.0 ± 0.01.0 ± 0.02.4 ± 0.5\<0.001\*\*n/aHippocampal volume (R)3,909.8 ± 105.53,667.3 ± 151.53,847.8 ± 202.40.500.58Hippocampal volume (L)3,695.1 ± 128.53,419.5 ± 171.83,578.0 ± 114.40.390.51Hippocampal MD (R) (10^−3^)1.004 ± 0.0520.998 ± 0.0511.084 ± 0.0880.002\*\*0.01\*\*Hippocampal MD (L) (10^−3^)0.946 ± 0.0400.965 ± 0.0971.032 ± 0.0800.02\*0.05\*DMS percent correct simultaneous90.7 ± 10.090.0 ± 14.180.0 ± 15.60.12n/aDMS percent correct all delay76.9 ± 2.871.1 ± 3.661.0 ± 4.90.02\*n/aPAL total trials adjusted14.5 ± 5.024.8 ± 14.425.3 ± 8.70.02\*0.05\*PAL first trial memory score16.7 ± 3.312.8 ± 4.710.6 ± 4.90.006\*\*0.02\*PAL total errors adjusted24.8 ± 29.666.7 ± 61.071.6 ± 46.00.04\*0.08PAL stages completed7.8 ± 0.46.9 ± 1.97.2 ± 1.30.230.40Continuous data are presented in mean ± SD. *p* values of two group comparisons were calculated using Independent-Samples *t* tests (Chi-squared test for gender and affected body side); *p* values of three group comparisons were calculated using One-way ANOVA*MMSE* Mini-mental State Examination, *MADRS-S* Montgomery--Åsberg Depression Rating Scale---self-assessment, *UPDRS-III* Unified Parkinson's Disease Rating Scale, part three, *VH symptom score* the first item score of PPRS, Parkinson Psychosis Rating Scale, *DMS* delayed matching to sample, *PAL* paired associates learning, *PDnonVH* Parkinson's disease without visual hallucination, *PDVH* Parkinson's Disease with visual hallucination, *R* right side, *L* left side, *B* both, *n*/*a* not applicable, *p value* (*covaried*) *p* value controlled for age and MMSE^a^Non-parametric tests, the description is median (percentile 25, percentile 75)\* *p* \< 0.05\*\* *p* \< 0.01

Visuospatial memory and non-spatial memory test {#Sec4}
-----------------------------------------------

Visuospatial memory was tested using subtests of the Cambridge Neuropsychological Test Automated Battery (CANTAB; Cambridge Cognition Ltd) (Robbins et al. [@CR66]): Paired Associates Learning (PAL). Two patients with PDVH did not carry out the PAL test. Since PDVH has been linked to impaired visual accuracy (Matsui et al. [@CR51]), which can confound interpretation of visuospatial memory performance, the DMS (Delayed Matching to Sample) test in 'spontaneous exhibition mode' (without any memory load) was used to provide a baseline measure of visual accuracy in participants and controlled in PAL analyses. The DMS test was run in 'delay exhibition mode' and was used to provide a measure of non-spatial working memory.

MRI data acquisition {#Sec5}
--------------------

MRI scans were carried out on a 3.0 T Philips MRI scanner. Three-dimensional T1-weighted anatomical MRI were acquired with fast field echo sequence (Magnetization Prepared Rapid Gradient Echo, MPRAGE), with the following parameters: TR = 6,895 ms; TE = 3.16 ms; FA = 8°; 1 × 1 × 1 mm^3^ voxels; FOV = 250 × 250 × 155 mm^3^; number of slices = 155.

Diffusion-weighted images were collected using a single-shot spin-echo imaging sequence with a voxel size of 2 × 2×2 mm^3^ with the following parameters: FOV = 225 × 180 × 225 mm^3^, acquisition matrix = 112 × 112; TR = 11,948 ms; TE = 65 ms; flip angle = 90°; slice thickness = 2 mm; number of slices = 90. Diffusion sensitizing gradients (*b* = 1,000 s/mm^2^) were applied in 16 directions. One additional image was collected without diffusion gradient (*b*~0~ = 0 s/mm^2^). Scanning was repeated twice to increase the signal/noise ratio.

The functional imaging data were acquired using a gradient-echo echo-planar imaging (EPI) sequence sensitive to BOLD contrast (Kwong et al. [@CR47]; Ogawa et al. [@CR59]). Acquisition parameters were: TR = 1,800 ms; TE = 30 ms; flip angle = 90°; 220 volumes; 45 contiguous axial slices; anterior--posterior acquisition; in-plane resolution = 3.75 × 3.75 mm^2^; slice thickness = 4 mm; field of view = 240 × 180 × 240 mm^3^; acquisition time = 6.6 min. Slice acquisition order was contiguous. Earplugs were used to reduce scanner noise and head motion was restricted by a foam pillow, as well as extendable padded head clamps. Participants were asked to simply rest in the scanner with their eyes closed before each resting-state scan and not fall asleep while remaining as still as possible.

Image preprocessing {#Sec6}
-------------------

T1-weighted structural data were processed with the VBM8 toolbox (<http://dbm.neuro.uni-jena.de/vbm/>) in SPM8 (<http://www.fil.ion.ucl.ac.uk/>) using Matlab (Matlab 7, The MathWorks, Natick, MA, USA). T1-weighted images were bias-corrected and segmented into gray matter (GM), white matter (WM), and CSF, and then affine normalized to MNI space. Tissue class images were then non-linearly normalized using the high-dimensional DARTEL (Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra) algorithm to study-specific templates created by DARTEL. The transformation matrix was then applied to T1-aligned MD, resting fMRI maps and original segmented hippocampal structures (see below).

Mean modulated and smoothed gray matter maps (gray matter intensity threshold = 0.2) were used to generate a group gray matter mask and applied as a mask for analyzing functional connectivity differences in between-group comparisons, specific to the groups involved in a particular test.

DTI data were pre-processed and analyzed using FMRIB Software Library, version 4.1 (FSL; <http://www.fmrib.ox.ac.uk/fsl>). Diffusion-weighted images were converted from dicom to nifti format, and corrected for eddy currents and subject motion by affine registration to the first b0 image using the FSL "eddy_correct" function. Diffusion tensors were linearly fitted to the diffusion-weighted images using the FSL tool "dtifit" to generate an MD output map.

Resting fMRI data preprocessing was performed using SPM8 (<http://www.fil.ion.ucl.ac.uk/spm>). First, all functional images were corrected for slice timing as well as head movement. Participants with excessive head movement \>2.5 mm of displacement or \>2.5° of rotation in any direction were discarded (four PDnonVH patients and two PDVH patients). Prior to band-pass filtering (0.01--0.08 Hz) which controls for the physiological "noise"(cardiac and respiratory-related artifacts), the following nuisance covariates were regressed from the BOLD signal (Weissenbacher et al. [@CR81]): six rigid-body parameters; white matter signal; cerebrospinal fluid signal.

Measurement of head motion {#Sec7}
--------------------------

As described by others (Van Dijk et al. [@CR76]; Satterthwaite et al. [@CR70]), our measurement of head motion was mean motion, which represents the mean absolute volume-to-volume displacement of each brain estimated from the translation parameters in the *x* (left/right), *y* (anterior/posterior), and *z* (superior/inferior) directions \[displacement = square root (*x*^2^ + *y*^2^ + *z*^2^)\] and expressed in mm. Given that movement has an impact on ALFF (Satterthwaite et al. [@CR70]), and mean motion linearly correlates with ALFF in diverse brain regions, the mean motion parameter was estimated and compared in both analyses.

Hippocampal volume and mean MD {#Sec8}
------------------------------

To register DTI data to the T1-weighted images, we calculated a full affine transformation from FA maps to brain-extracted whole-brain volumes of T1-weighted images (Carlesimo et al. [@CR13]) using FLIRT (Jenkinson and Smith [@CR43]; Jenkinson et al. [@CR44]). The transformation matrix was then applied to the MD maps. Bilateral hippocampus of anatomical T1-weighted images were then automatically segmented using FIRST (Patenaude et al. [@CR62]) by running a two-stage affine registration to MNI152 space. Segmented structures were used as binary masks for which mean MD was calculated from realigned MD map for each individual.

Vertex analysis {#Sec9}
---------------

FIRST was used to investigate localized shape differences in the hippocampus. A surface mesh was created for each hippocampus using a deformable mesh model, and aligned to a common space prior to investigating group differences. The mean surface from the FIRST models (in MNI152 space) was used as the target to which surfaces from each individual were aligned. Vertex analysis was performed using first utils (Patenaude et al. [@CR62]) and hippocampal shape difference was assessed on a per vertex basis. Regional differences in the vertices across the three groups were assessed using a global linear model. The results were corrected for multiple comparisons using a family-wise error (family-wise error, *p* \< 0.05) correction.

Voxel-based MD in hippocampal regions {#Sec10}
-------------------------------------

MD maps were normalized to the Montreal Neurological Institute (MNI) space by applying the transformation parameters obtained from the structural images. A normalized hippocampal mask was applied in each group comparison for statistical analysis of hippocampal MD.

Functional Connectivity of hippocampus {#Sec11}
--------------------------------------

Functional connectivity was based on a seed-region approach and conducted in MNI space. For each participant, the mean time series was extracted from bilateral hippocampal regions defined by fMRI-realigned hippocampus, and correlated with the appropriate time series at all other brain voxels in the original acquisition space using Pearson's coefficient of correlation followed by Fisher's *r*- to -*z* transformation. Functional connectivity maps were then normalized to the Montreal Neurological Institute (MNI) space by applying the transformation parameters obtained from the structural images to those time and motion corrected and nuisance covaried images, resampled (3 × 3 × 3 voxels) and smoothed (4-mm full width at half maximum (FWHM) Gaussian kernel).

Statistical analysis {#Sec12}
--------------------

Between-group voxel-wise comparisons were performed using two sample t test. Voxel-by-voxel statistical analysis of MD differences between PDVH, PDnonVH and healthy controls was restricted to within the hippocampal mask, and the results were corrected for multiple comparisons (family-wise error) using a threshold of *p* \< 0.05. The functional connectivity statistical comparisons were restricted within the corresponding gray matter mask. The statistical tests for functional connectivity were corrected for multiple comparisons to a significance level of *p* \< 0.05 using Monte Carlo simulations (uncorrected single voxel significance level of *p* \< 0.05 and a minimum cluster size based on the size of the gray matter mask of each load of comparison) (Ledberg et al. [@CR48]). Age and MMSE score were introduced as nuisance covariates in all statistical analyses.

One-way ANOVA was used to compare demographic factors, visual-memory scores, hippocampal MD and volume using Statistical Package for Social Sciences (version 15.0.1) (SPSS for Windows 2006). Post hoc tests were carried out where appropriate. Mean hippocampal functional connectivity *z* scores were calculated for each cluster which had a difference between PDVH and PDnonVH, and Pearson correlation co-efficients between hippocampal MD, mean functional connectivity *z* scores, visual hallucinations severity and visuospatial memory score were calculated in PDVH group. Age and MMSE scores were controlled for within-group comparisons of hippocampal volume and MD, and intracranial volume was additionally controlled in group comparisons of hippocampal volume. Age and visual accuracy (DMS score) were controlled in PAL between-group comparisons and correlational analyses. The relationship between levodopa-equivalent dosage and bilateral hippocampal MD/functional connectivity results in PD patients was assessed with Pearson correlation analysis. A similar analysis between PD severity (UPDRS-III score) and bilateral hippocampal MD/functional connectivity results in the PD group was also undertaken. Pearson Chi-square tests between gender and hippocampal MD/functional connectivity results in the PD group were carried out as well.

Results {#Sec13}
=======

Demographic and clinical profile {#Sec14}
--------------------------------

Clinical data comparisons are summarized in Table [1](#Tab1){ref-type="table"}. Participants were matched for age (\>55 years), gender, education, and MMSE score. The PD groups were also balanced for duration of illness, drug dosage, and PD symptom severity. In PDVH group, five reported having visual hallucinations about 1--3 times per month, five had visual hallucinations 1--2 times per week, and two reported having visual hallucinations every day. Nine patients experienced visual hallucinations of people, 1 subject of animal and objects, one of only objects, and one patient experienced "presence of a person" hallucinations. Three patients with visual hallucinations were under antipsychotic drug quetiapine. Two patients reported visual illusions in addition to visual hallucinations. No patient experienced delusion or delirium. PD patients were receiving levodopa medication. Participants were asked if they experienced hallucinations in the scanner---none were reported.

No group differences in visual accuracy {#Sec15}
---------------------------------------

The three groups did not differ significantly in visual accuracy. This parameter was included as a 'nuisance' covariate for later correlation and group comparison analyses of performance in the visuospatial memory test (PAL).

Visuospatial memory was impaired in PD {#Sec16}
--------------------------------------

PD groups had significantly poorer performance than controls on PAL indices. Post hoc tests (see Supplementary Table 1; Supplementary Fig. 1) confirmed both PDVH and PDnonVH groups performed worse than the HC group and there was no significant difference between PDVH and PDnonVH.

Hippocampal MD was increased in PDVH {#Sec17}
------------------------------------

There were no group differences in overall hippocampal volume and shape, but PDVH had higher MD values in the right hippocampus compared to PDnonVH and HC groups, and greater MD in left hippocampus compared to HC.

In voxel-by-voxel analyses, the PDVH group had greater MD in right posterior hippocampal regions compared to PDnonVH and HC groups and greater MD in left hippocampal body compared to HC. There was no correlation between visual spatial memory score and hippocampal MD in PDVH group. There was no significant correlation between levodopa-equivalent dosage/gender and bilateral hippocampal MD results in PD patients, and no significant correlation between PD severity and hippocampal results in PD patients (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Group differences in hippocampal MD. Voxel-by-voxel analyses of increased hippocampal diffusivity in patients with Parkinson disease with visual hallucinations compared with healthy controls and PD individuals without visual hallucinations. Statistical results are superimposed on the standard Montreal Neurological Institute template (*x* coordinates are reported). Age and MMSE were controlled. The *green line* in the *bottom panel* shows the middle plane (*y* = −22 mm) of the right hippocampal mask generated in this study

The severity of visual hallucinations is linked with impaired visual-memory performance {#Sec18}
---------------------------------------------------------------------------------------

The severity of visual hallucinations indexed by PPRS question 1 was correlated with visuospatial memory performance in PDVH group. The correlation coefficients with visual hallucinations severity were: PAL Total trials adjusted *r* = 0.694, *p* \< 0.05; PAL First trial memory *r* = −0.686, *p* \< 0.05; PAL Total errors adjusted *r* = 0.843, *p* \< 0.01; PAL Stages completed *r* = −0.725, *p* \< 0.05.

Functional connectivity {#Sec19}
-----------------------

Both PD groups had lower hippocampal functional connectivity across widespread cortical areas compared to HC. In the PDnonVH group, lower hippocampal functional connectivity was mainly located in parieto-frontal regions, whereas in PDVH group, lower hippocampal functional connectivity was mainly located in occipito-parietal and temporal regions (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Group differences in hippocampal functional connectivity. Statistical results are superimposed on the standard Montreal Neurological Institute template (*x* coordinates are reported) (mm) at the given threshold corrected for multiple comparisons \[Monte-Carlo Simulation, cluster size = 1,701 mm^3^ (63 voxels), in comparison between HC and PDnonVH, *T* \> 2.06 (or *T* \< −2.06) in comparison between HC and PDVH, and in comparison between PDnonVH and PDVH, *T* \> 2.07 (or *T* \< −2.07)\]. Age and MMSE scores are entered as covariables. In *each panel*, *blue* indicates relatively lower functional connectivity in the second group compared to the first; *red* indicates the reverse. The *right side* of the figure is the left side of the brain. *L* functional connectivity with left hippocampus, *R* functional connectivity with the right hippocampus

Compared to PDnonVH, PDVH had lower functional connectivity between right hippocampus and bilateral cuneus and lingual gyrus, right fusiform gyrus, right medial temporal lobe and left superior/middle temporal gyrus, as well as lower FC between left hippocampus and bilateral lingual gyrus, right fusiform gyrus, left cuneus, right medial temporal lobe and right precuneus. PDVH also had greater hippocampal FC in bilateral frontal lobe, cingulate cortex, and inferior parietal lobe which are components of default mode network and salience network (Fig. [2](#Tab2){ref-type="table"}; Table [2](#Tab2){ref-type="table"}).Table 2Group differences between PDnonVH and PDVH in hippocampal functional connectivityFCNumber of voxels*xyz*SideBrain regionsBA*T* valueLeft hippocampus Lower in PDVH1080−96−18LOccipital lobe/lingual gyrus18/17−3.477522733−90−12RInferior occipital gyrus/lingual gyrus/fusiform gyrus18/17−4.727116518−519RMedial temporal lobe/parahippocampa gyrus/precuneus/fusiform gyrus/lingual gyrus37/19−3.47673−9−9318LMiddle occipital gyrus/cuneus19/18−3.5145730−5751L/RParietal lobe/precuneus7−3.3123 Higher in PDVH14642246RInferior frontal gyrus/middle frontal gyrus/insula/inferior orbital frontal gyrus11/133.8879196275730RMiddle frontal gyrus/superior frontal gyrus104.484216163−3345RInferior parietal lobe/postcentral gyrus403.5631555−61839R/LSuperior frontal lobe/anterior cingulate gyrus/medial temporal lobe/medial frontal gyrus/24/32/6/234.525395−392424LMiddle frontal gyrus/inferior frontal gyrus/superior frontal gyrus93.728996−63−3945LInferior parietal lobe/supramarginal gyrus/superior temporal gyrus403.35319245354RMiddle frontal lobe/Precentral gyrus63.3516Right hippocampus Lower in PDVH103−3621−24LSuperior temporal gyrus/middle temporal gyrus/38−3.608215633−90−12RInferior occipital gyrus/lingual gyrus/middle occipital gyrus18−4.709117−24−105−6LInferior occipital gyrus/lingual gyrus/cuneus18−4.351437927−48−6RMedial temporal lobe/lingual gyrus/fusiform gyrus/parahippocampal gyrus/cuneus/cerebellum19/30/17/18−4.7061105−27−8121LMiddle occipital gyrus/cuneus/superior occipital lobe19/18−3.8056 Higher in PDVH108274524RMiddle frontal gyrus/superior frontal gyrus103.506967−3−2424LPosterior cingulate cortex/medial temporal lobe233.988671−48−348LFrontal lobe/precentral gyrus6/43.77589436945RMiddle frontal gyrus/superior frontal gyrus63.6509Group differences in functional connectivity are shown at *p* \< 0.05 corrected for multiple comparisons \[cluster size = 1,701 mm^3^, *T* \> 2.07 (or *T* \< −2.07)\]. *x*, *y*, *z* coordinates in the MNI atlas extend from *z* = −60 to *z* = +85 mm. *T* values are from a *t* test of the peak voxel (showing greatest statistical difference within a cluster), and a negative *T* value means lower ALFF in PDVH group. Age and MMSE scores are regressed out as nuisance variables*BA* Brodmann area, *L*, *R* left and right

Moreover, we carried out a correlation study between the mean functional connectivity *z* scores in the clusters with significant difference between PDVH and PDnonVH and cognitive tests (see Supplementary Table 2). The results showed that PDVH group has lower right hippocampal functional connectivity with right occipital gyrus (peak voxel of the cluster: *x* = 33, *y* = −90, *z* = −12) and right medial temporal regions (peak voxel of the cluster: *x* = 27, *y* = −48, *z* = −6), and the mean functional connectivity *z* scores in the two clusters were associated with worse visuospatial memory performance (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Correlation analyses of hippocampal functional connectivity and visuospatial memory performance. **a** T map of the two clusters showing significant correlation between functional connectivity and visuospatial memory score in PDVH patients. MNI coordinates (*x*, *y*, *z*): *top right* occipital gyrus = 33, −90, −12; *bottom right* medial temporal lobe = 27, −48, −6 (only clusters with decreased functional connectivity in PDVH are shown here). **b** *Bar graphs* of the region of interest (ROI)---average functional connectivity *z* scores (±standard error) for patient groups and HC group in right occipital gyrus (HCs 0.172; PDnonVH 0.126; PDVH 0.012; *p* \< 0.001) and right medial temporal lobe (HCs 0.199; PDnonVH 0.183; PDVH 0.053; *p* \< 0.001). **c** Correlation between hippocampal functional connectivity *z* score and visuospatial memory performance (PAL scores) in PDVH group. Scatterplot of ROI-averaged functional connectivity *z* scores from occipital cluster (with total trial adjusted score: *r* = 0.719, *p* \< 0.05) and medial temporal cluster against visuospatial memory scores (with total trial adjusted score: *r* = 0.772, *p* \< 0.05). Correlation coefficients were controlled for age and visual accuracy scores

There was no significant correlation between levodopa-equivalent dosage/gender and functional connectivity in PD (please see bottom panel of Fig. [2](#Fig2){ref-type="fig"}), and no significant correlation between PD severity and functional connectivity in patients.

Discussion {#Sec20}
==========

The current study, for the first time, reports the microstructural and functional connectivity differences in the hippocampus in PD patients with visual hallucinations, and it correlates with the extent to which visuospatial memory is impaired with hippocampal pathology and visual hallucination severity. Our study thus consolidates a pivotal role of hippocampus in the production of visual hallucinations in PD, similar to its reported role in other psychosis such as schizophrenia (Amad et al. [@CR2]).

Hippocampal microstructure {#Sec21}
--------------------------

The results are consistent with our hypothesis that hippocampal microstructure is altered in individuals with PD and visual hallucinations compared to both PDnonVH and HC. The patients with visual hallucinations had higher MD in right hippocampus relative to both PDnonVH and HC groups, and higher MD in left hippocampus relative to HCs. The results remained significant when possible confounds due to age (Lim et al. [@CR49]; Driscoll and Sutherland [@CR21]) and cognitive ability were controlled (using the MMSE and DMS measure of non-spatial working memory).

Our results are partly in line with previous findings of hippocampal gray matter deficits in PD hallucinators (Ibarretxe-Bilbao et al. [@CR40]) in which a whole-brain voxel-based analysis found no significant gray matter intensity difference between PDVH and PDnonVH. Ibarretxe-Bilbao and colleagues did report a hippocampal 'volume' deficit in PDVH patients compared to HCs, whereas we found no hippocampal volume differences between groups. Our result is, however, consistent with a recent study of whole-brain macrostructural differences in PD, which also observed no volume alterations in the hippocampus (Gama et al. [@CR31]).

Although the neural mechanism of abnormal diffusivity in gray matter structures is not fully understood, it is generally assumed that, in pathologic states, greater diffusivity signals more water content or disruption and break-down of tissue cytoarchitecture (den Heijer et al. [@CR18]). For example, progressive loss of cellular barriers or an increase in extracellular water space in neurodegeneration could lead to an increase in MD (Basser and Pierpaoli [@CR6]; den Heijer et al. [@CR18]), and reflect a deterioration in the efficacy of synaptic and extrasynaptic transmission (Sykova and Nicholson [@CR74]). Resonating with this idea, increased gray matter MD has been linked to impaired cognitive performance in mild cognitive impairment or Alzheimer's disease (Muller et al. [@CR56]; Cherubini et al. [@CR16]). Together with the absence of group differences in hippocampal volume and shape observed here, normal neuron counts in the hippocampus in PD, but increased Lewy bodies in the hippocampal regions of those with PDVH (Churchyard and Lees [@CR17]; Kalaitzakis et al. [@CR45]; Gallagher et al. [@CR30]), one possibility is that that increased hippocampal diffusivity in patients with visual hallucinations may be due to disruption caused by α-synuclein deposition in neurons. An alternative explanation is that, because MD is sensitive to water content, and hence to CSF around the hippocampus, greater MD could be a 'partial volume' effect, due to a smaller hippocampus size (and hence more CSF in the DTI voxels). However, although we observed a trend level difference in hippocampal size across the groups in this study (*p* = 0.08), compared to controls, the hippocampus was actually smaller in the PDnonVH group, but gray matter MD was not increased in this group. This suggests that volume and gray matter MD are relatively independent indices, and the increase in hippocampal MD in PDVH cannot easily be explained by a decrease in volume.

Significant MD alteration was localized to the posterior right hippocampus in the PDVH group compared to both PDnonVH and HC. In primates, the posterior portions of the hippocampus correspond to the rodent dorsal hippocampus, which is needed for visuospatial memory processing, while the ventral (anterior) part of hippocampus is involved in non-spatial memory and emotional behavior (Behrendt [@CR8]; Fanselow and Dong [@CR24]). Greater diffusivity in right posterior hippocampus and impaired spatial memory performance in PDVH is consistent with a possible mediating role for impaired visuospatial memory in the generation of VH; indeed, visuospatial memory impairment was correlated with the severity of visual hallucinations.

Hippocampal functional connectivity {#Sec22}
-----------------------------------

The segmented hippocampus was used as seed region of interest to investigate functional connectivity with the rest of the brain. Compared with the PDnonVH group, PD hallucinators had lower functional connectivity between hippocampus and cuneus, lingual gyrus, fusiform gyrus, medial temporal lobe, superior/middle temporal gyrus, and precuneus. The parietal regions belong to the dorsal visual pathway, whereas the temporal regions belong to the ventral visual pathway. Both pathways originate in occipital regions then project through inferior parietal and inferior temporal gyri respectively to the perirhinal-hippocampal cortices (Behrendt [@CR8]). The latter is critical for complex visual processing including memory, image perception, and internal expectations (Downing et al. [@CR20]; Rolls and Xiang [@CR68]; Bussey and Saksida [@CR12]; Cerf et al. [@CR14]), as well as contextual and scene representation (Chen et al. [@CR15]; Hebart and Hesselmann [@CR38]) and visuospatial attention (Nassi and Callaway [@CR57]). Thus, the hippocampus is in a unique position for the conjunction of stimulus-related and spatial and non-spatial contextual information processed in parietal (dorsal) and temporal (ventral) regions (Behrendt [@CR8]). Our results fit well with this notion that integration of the dorsal and ventral visual streams in the hippocampus is disrupted in patients with visual hallucinations. They are also consistent with previous studies, suggesting that disorganization of neuronal spikes in hippocampus might disrupt integration of ventral/dorsal information and induce visual hallucination rather than reflect reality (Olypher et al. [@CR60]).

The patients with visual hallucinations had greater functional connectivity between the hippocampus and regional components of the default mode network (DMN) (including medial frontal gyrus, posterior cingulate cortex (PCC) and bilateral inferior parietal gyrus) and 'salience' network \[composed of anterior insula and anterior cingulate gyrus (ACC)\]. This extends our previous work showing that this cohort of PD patients with visual hallucinations have greater connectivity within the DMN itself (Yao et al. [@CR83]).

The DMN processes spontaneous thoughts, consciousness, memory, and social cognition in resting state (Raichle et al. [@CR65]; Greicius et al. [@CR34]; Buckner et al. [@CR11]), and is known to be functionally and structurally connected with hippocampal and parahippocampal regions (Buckner et al. [@CR11]; Ward et al. [@CR80]). The salience network is also involved in integration and "harmonization" of external sensory stimuli and internal states (Seeley et al. [@CR71]), (Sridharan et al. [@CR72]). Thus abnormalities in hippocampus/DMN/salience network connectivity fits with theories that visual hallucinations result from limited "bottom-up" peripheral sensory input from primary visual cortex and unconstrained "top-down" processing of endogenous memories and attention from frontal regions (Bar et al. [@CR4]; Behrendt [@CR8]; Onofrj et al. [@CR61]).

Hippocampal functional connectivity correlates with visuospatial memory performance {#Sec23}
-----------------------------------------------------------------------------------

We found a correlation between functional connectivity and visual--spatial memory in PDVH individuals. Moreover, visual hallucinations severity was associated with visuospatial memory in patients with visual hallucinations. These results support the notion that both disrupted intrinsic integration with attenuated extrinsic visual stimuli from primary visual cortex contribute to reduced visuospatial memory performance, thus might underlie visual hallucinations in PD.

To sum up, the present multimodal MRI techniques provided reliable and novel results. The microstructural and functional connectivity findings are consistent with the hypothesis of imbalanced integration of internal memory and external visual input (Diederich et al. [@CR19]; Goetz [@CR32]) which contribute to visual hallucinations in Parkinson's disease, and implicating that this pathological phenomenon can be underlied by the microstructural deficit and dysfunction in hippocampus. The consistent result of the hippocampal biomarker indicated in the present study supports future development of therapeutic strategy on the basis of neuro-guided stimulation approach, such as transcranial magnetic stimulation (TMS) (Liu et al. [@CR50]) and transcranial direct current stimulation (tDCS) (Brunoni et al. [@CR10]) to modulate the connectivity strength of visual networks.

Limitations {#Sec24}
-----------

We acknowledge that our study had a relatively modest sample size. However, given the practical difficulty in recruiting and scanning this population, our numbers compare favorably to the existing literature. To compensate for the limited sample size, we pursued a multimodal approach which provided highly convergent findings supporting hippocampal pathology and visuospatial memory impairment in PD patients with visual hallucinations.

The levodopa-equivalent dosage is not perfectly matched in our PD patients with and without visual hallucinations, and this might contribute to result bias. The side-effects of pro-dopaminergic medication were originally assumed to be the most important causal factor for VH in PD (Moskovitz et al. [@CR54]), however, more recent evidence suggests VH is an intrinsic part of PD (Sanchez-Ramos et al. [@CR69]; Fenelon et al. [@CR26]; Merims et al. [@CR53]). Moreover, when we controlled levodopa-equivalent dosage in our analysis, the result did not change (see Supplementary Fig. 2).

We also acknowledge the MMSE used in our study is a rather insensitive instrument for measurement of memory function and memory impairment is common in non-demented patients with PD (Yarnall et al. [@CR82]). However, when the levodopa**-**equivalent dose, non-spatial memory performance and head movement were included as covariates the pattern of results did not alter (please see Supplementary Fig. 2). Moreover, three patients with hallucinations also received antipsychotic medication, and while it is possible that our results could potentially be influenced by this treatment, if anything, this should minimize the relationship between hallucination severity and impaired visuospatial memory observed here.

The cross-sectional nature of our study prevents us from drawing causal conclusions. Although we suggest a link between low hippocampal diffusivity and low hippocampal functional connectivity, poor visuospatial memory performance, and visual hallucinations in PD, it may be that visuospatial ability and visual hallucinations are simply comorbid symptoms induced by hippocampal deterioration and dysfunction. Future studies with larger sample sizes will help excavate causal evidence for visual hallucinations in PD.

Finally, there are several other potential methodological limitations to the interpretation of the data. First, we could not completely avoid the effects of physiological 'noise' during resting fMRI scans (such as cardiac and respiratory pulsation), that can feature in the resting-state low-frequency rage (0.01--0.08 Hz). However, a low-pass filtering at a cut-off of 0.08 Hz was used in our study to control for physiological "noise" (Fox and Raichle [@CR28]). Second, the patients with visual hallucinations recruited in this study had no obvious depression or dementia, which is quite rare in people with PD and hallucinations (Fenelon and Alves [@CR25]), so we are cautious in generalizing our findings more severely affected individuals.

Conclusions {#Sec25}
===========

The innovative multimodal imaging approach in the current study revealed a microstructural deficit in right hippocampal region in PD patients with visual hallucinations compared to PD non-hallucinators. This impairment was associated with altered functional connectivity in hippocampus across regions involved in integrative processing of visual information, and with impaired visuospatial memory processing in visual hallucinations. Since visual hallucinations herald a poor prognosis in Parkinson's disesase, these findings may pave the way for future studies of imaging biomarkers or tools to measure treatment response in those most at risk.
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Group differences between PDnonVH and PDVH in hippocampal functional connectivity. Statistical results are superimposed on the standard Montreal Neurological Institute template (x coordinates are reported) (mm) at the given threshold corrected for multiple comparisons (Monte-Carlo Simulation, cluster size=1701 mm^3^ (63 voxels), in comparison between PDnonVH and PDVH, T\>2.09 (or T\<−2.09)). Age, MMSE scores, levodopa-equivalent dosage, head motion and working memory scores were entered as covariables. In each panel, blue indicates relatively lower functional connectivity in PDVH compared to PDnonVH; red indicates the reverse. The right side of the figure is the left side of the brain. L = functional connectivity with left hippocampus; R = functional connectivity with the right hippocampus. Supplementary material 4 (TIFF 2,027 kb)
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